BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 12442275)

  • 41. Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing.
    De Leeneer K; Coene I; Crombez B; Simkens J; Van den Broecke R; Bols A; Stragier B; Vanhoutte I; De Paepe A; Poppe B; Claes K
    Breast Cancer Res Treat; 2012 Feb; 132(1):87-95. PubMed ID: 21553119
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects.
    Díez O; Osorio A; Durán M; Martinez-Ferrandis JI; de la Hoya M; Salazar R; Vega A; Campos B; Rodríguez-López R; Velasco E; Chaves J; Díaz-Rubio E; Jesús Cruz J; Torres M; Esteban E; Cervantes A; Alonso C; San Román JM; González-Sarmiento R; Miner C; Carracedo A; Eugenia Armengod M; Caldés T; Benítez J; Baiget M
    Hum Mutat; 2003 Oct; 22(4):301-12. PubMed ID: 12955716
    [TBL] [Abstract][Full Text] [Related]  

  • 43. BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives.
    Lalloo F; Varley J; Moran A; Ellis D; O'dair L; Pharoah P; Antoniou A; Hartley R; Shenton A; Seal S; Bulman B; Howell A; Evans DG
    Eur J Cancer; 2006 May; 42(8):1143-50. PubMed ID: 16644204
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutational analysis of BRCA1 and BRCA2 in Mediterranean Spanish women with early-onset breast cancer: identification of three novel pathogenic mutations.
    Martínez-Ferrandis JI; Vega A; Chirivella I; Marín-García P; Insa A; Lluch A; Carracedo A; Chaves FJ; García-Conde J; Cervantes A; Armengod ME
    Hum Mutat; 2003 Nov; 22(5):417-8. PubMed ID: 14517958
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A high proportion of DNA variants of BRCA1 and BRCA2 is associated with aberrant splicing in breast/ovarian cancer patients.
    Sanz DJ; Acedo A; Infante M; Durán M; Pérez-Cabornero L; Esteban-Cardeñosa E; Lastra E; Pagani F; Miner C; Velasco EA
    Clin Cancer Res; 2010 Mar; 16(6):1957-67. PubMed ID: 20215541
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The prevalence of germline BRCA1 and BRCA2 mutations in young women with breast cancer undergoing breast-conservation therapy.
    Golshan M; Miron A; Nixon AJ; Garber JE; Cash EP; Iglehart JD; Harris JR; Wong JS
    Am J Surg; 2006 Jul; 192(1):58-62. PubMed ID: 16769276
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of two different models to predict BRCA1 and BRCA2 mutations in a cohort of Danish hereditary breast and/or ovarian cancer families.
    Gerdes AM; Cruger DG; Thomassen M; Kruse TA
    Clin Genet; 2006 Feb; 69(2):171-8. PubMed ID: 16433698
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel somatic mutations in the BRCA1 gene in sporadic breast tumors.
    Janatova M; Zikan M; Dundr P; Matous B; Pohlreich P
    Hum Mutat; 2005 Mar; 25(3):319. PubMed ID: 15712267
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of germline BRCA1 and BRCA2 genetic alterations in Greek breast cancer moderate-risk and low-risk individuals--correlation with clinicopathological data.
    Kataki A; Gomatos I; Pararas N; Armakolas A; Panousopoulos D; Karantzikos G; Voros D; Zografos G; Markopoulos C; Leandros E; Konstadoulakis M
    Clin Genet; 2005 Apr; 67(4):322-9. PubMed ID: 15733268
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The analysis of BRCA1 mutations in eastern Chinese patients with early onset breast cancer and affected relatives.
    Hu Z; Wu J; Liu CH; Lu JS; Luo JM; Han QX; Shen ZZ; Shao ZM
    Hum Mutat; 2003 Jul; 22(1):104. PubMed ID: 12815604
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hereditary breast and ovarian cancer in Cyprus: identification of a founder BRCA2 mutation.
    Hadjisavvas A; Charalambous E; Adamou A; Neuhausen SL; Christodoulou CG; Kyriacou K
    Cancer Genet Cytogenet; 2004 Jun; 151(2):152-6. PubMed ID: 15172753
    [TBL] [Abstract][Full Text] [Related]  

  • 52. BRCA1 germline mutations in Indian familial breast cancer.
    Valarmathi MT; A A; Deo SS; Shukla NK; Das SN
    Hum Mutat; 2003 Jan; 21(1):98-9. PubMed ID: 12497638
    [TBL] [Abstract][Full Text] [Related]  

  • 53. BRCA1 and BRCA2 have a limited role in familial prostate cancer.
    Sinclair CS; Berry R; Schaid D; Thibodeau SN; Couch FJ
    Cancer Res; 2000 Mar; 60(5):1371-5. PubMed ID: 10728701
    [TBL] [Abstract][Full Text] [Related]  

  • 54. BRCA2 gene mutations in Greek patients with familial breast cancer.
    Armakolas A; Ladopoulou A; Konstantopoulou I; Pararas B; Gomatos IP; Kataki A; Konstadoulakis MM; Stathopoulos GP; Markopoulos C; Leandros E; Gogas I; Yannoukakos D; Androulakis G
    Hum Mutat; 2002 Jan; 19(1):81-2. PubMed ID: 11754111
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Study of BRCA1 and BRCA2 gene mutations in human sporadic breast cancers].
    Zhang HT; Lu YF; Zeng J; Lin J; Liao QH; Wan FQ
    Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):480-2. PubMed ID: 17686308
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Frequent somatic mutations of GATA3 in non-BRCA1/BRCA2 familial breast tumors, but not in BRCA1-, BRCA2- or sporadic breast tumors.
    Arnold JM; Choong DY; Thompson ER; ; Waddell N; Lindeman GJ; Visvader JE; Campbell IG; Chenevix-Trench G
    Breast Cancer Res Treat; 2010 Jan; 119(2):491-6. PubMed ID: 19189213
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of missense and truncating mutations in the BRCA1 gene in sporadic and familial breast and ovarian cancer.
    Greenman J; Mohammed S; Ellis D; Watts S; Scott G; Izatt L; Barnes D; Solomon E; Hodgson S; Mathew C
    Genes Chromosomes Cancer; 1998 Mar; 21(3):244-9. PubMed ID: 9523200
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Search for frequently encountered mutations in genes predisposing to breast cancer].
    Mandel'shtam MIu; Golubkov VI; Lamber EP; Shapiro IM; Brezhneva TV; Semiglazov VF; Lipovetskiĭ BM; Hanson KP; Gaĭtskhoki VS
    Genetika; 2001 Dec; 37(12):1681-6. PubMed ID: 11785296
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hereditary breast cancer: a review.
    Arver B; Du Q; Chen J; Luo L; Lindblom A
    Semin Cancer Biol; 2000 Aug; 10(4):271-88. PubMed ID: 10966850
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Breast Cancer Information Core.
    Couch FJ; Weber BL
    Hum Mutat; 1996; 8(1):8-18. PubMed ID: 8807330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.